Free Trial

Avidity Biosciences (RNA) SEC Filings & 10K Form

Avidity Biosciences logo
$32.20 -0.49 (-1.50%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$32.18 -0.02 (-0.05%)
As of 05/2/2025 04:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Avidity Biosciences SEC Filings

DateFilerForm TypeView
04/03/2025
3:56 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
7:50 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
5:38 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:40 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:42 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:44 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:36 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:23 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:35 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:17 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:59 PM
Avidity Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:13 PM
Avidity Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
10:24 AM
Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G
02/05/2025
4:01 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:34 PM
Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
7:12 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:14 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:15 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:17 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:06 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:08 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:10 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:25 PM
Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:35 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:22 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:24 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:26 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:29 PM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:31 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:13 PM
Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:14 PM
Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:16 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:52 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
6:04 PM
Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:42 PM
Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:46 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
8:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
5:15 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:15 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:16 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk's warning signal: Prepare before the cascade begins (Ad)

When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.

Watch the Musk market warning before the dominoes fall
12/19/2024
5:17 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:46 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
5:08 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:59 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
5:06 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
5:10 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
Avidity Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
8:39 AM
Avidity Biosciences (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G
11/12/2024
6:06 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:50 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
12:56 PM
Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/04/2024
9:22 AM
Avidity Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/30/2024
7:01 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
3:19 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
3:21 PM
Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
3:20 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
12:48 PM
Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
4:23 PM
Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:36 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
7:59 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:01 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:03 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:06 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:27 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
4:19 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:25 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:18 PM
Avidity Biosciences (Subject)
McCarthy Teresa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:18 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
5:26 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:46 PM
Avidity Biosciences (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
08/21/2024
3:30 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:43 PM
Avidity Biosciences (Filer)
Form 424B5
08/15/2024
3:46 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:20 PM
Avidity Biosciences (Filer)
Form 424B5
08/09/2024
4:12 PM
Avidity Biosciences (Filer)
Form 424B5
08/09/2024
3:20 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:23 PM
Avidity Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:46 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:11 AM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:06 AM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/23/2024
3:22 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:47 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:48 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:49 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:47 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:54 PM
Avidity Biosciences (Issuer)
Henig Noreen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:56 PM
Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:58 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

06/14/2024
6:01 PM
Avidity Biosciences (Issuer)
BOESS CARSTEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:03 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:06 PM
Avidity Biosciences (Issuer)
Kim Jean Jinsun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:07 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:09 PM
Avidity Biosciences (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:52 PM
Avidity Biosciences (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:05 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
3:19 PM
Avidity Biosciences (Filer)
Form 424B5
06/12/2024
3:22 PM
Avidity Biosciences (Subject)
Boyce Sarah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RNA) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners